Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Glen Ventures is a Montreal-based venture capital firm founded around 2024, focusing exclusively on early-stage health technology investments. As Quebec's sole early-stage VC dedicated to healthtech, Glen Ventures aims to catalyze innovation across the healthcare continuum. The firm is deeply connected to the McGill University Health Centre (MUHC), which enhances its ability to support startups through clinical collaboration and strategic business guidance.
The firm operates with a $5 million CAD fund, backed by the Eureka Investment Fund and capitalized by the Quebec government via Investissement Quebec. This fund is specifically designed to commercialize healthtech innovations emerging from Quebec's public research institutions. Glen Ventures is committed to identifying high-growth markets and providing resources that accelerate the journey from concept to market.
Glen Ventures invests in healthtech companies that demonstrate potential for global growth and significant market impact. The firm emphasizes transformative solutions that improve healthcare delivery, enhance patient outcomes, and promote overall wellness. Their investment strategy includes a focus on pre-seed, seed, seed+, and Series A stages, with check sizes ranging from $250,000 to $1,000,000 CAD.
The firm actively seeks startups that address critical gaps in healthcare, prioritizing life-changing innovations over incremental improvements. Glen Ventures leverages its strong ties with the McGill University Health Centre to provide hands-on support and mentorship, ensuring that portfolio companies receive the guidance necessary to navigate the complexities of the healthtech landscape.
Glen Ventures has invested in several notable healthtech companies, including:
These investments reflect Glen Ventures' commitment to supporting innovative healthtech solutions that have the potential to make a significant impact on patient care and healthcare delivery.
Michael Goodman — Founding Partner. Michael has extensive experience in venture capital and healthcare, having previously worked with leading firms in the sector. He has a strong background in identifying and supporting innovative healthtech startups.
Samuel Ohayon — Managing Partner. Samuel brings a multidisciplinary approach to Glen Ventures, with expertise spanning medicine, technology, and business. He has been instrumental in building the firm's portfolio and fostering relationships within the healthcare community.
Startups interested in pitching to Glen Ventures should send their proposals via email to info@glenventures.ca. A comprehensive pitch deck is essential, including details on the business model, market opportunity, competitive landscape, and team qualifications. Glen Ventures appreciates clear and concise presentations that highlight the startup's potential for transformative impact in healthtech.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred but not mandatory.
In December 2024, Glen Ventures secured a $5 million CAD mandate from the Eureka Investment Fund, capitalized by the Quebec government via Investissement Quebec. This funding is aimed at commercializing healthtech innovations from Quebec's public research institutions.
Recently, Glen Ventures has actively built its portfolio, making significant investments in healthtech companies such as Sensifai and Paperplane Therapeutics, which recently raised $1.5 million to expand its operations.
What are Glen Ventures' investment criteria?
Glen Ventures focuses on early-stage healthtech companies that demonstrate potential for global growth and market impact. They prioritize startups that offer transformative solutions in healthcare delivery and patient outcomes.
How can startups apply or pitch to Glen Ventures?
Startups can reach out via email at info@glenventures.ca to initiate a conversation. A detailed pitch deck outlining the business model, market opportunity, and team is recommended.
What makes Glen Ventures different from other VCs?
Glen Ventures is unique as Quebec's only early-stage VC dedicated exclusively to health technology. Their close ties with the McGill University Health Centre provide portfolio companies with access to clinical expertise and resources.
What is the geographic scope of Glen Ventures' investments?
The firm primarily invests in North America, with a specific focus on healthtech innovations emerging from Quebec and beyond.
What is the typical check size for investments?
Glen Ventures typically invests between $250,000 and $1,000,000 CAD in early-stage healthtech companies, with reserved capital for follow-on investments.
What kind of support do portfolio companies receive post-investment?
Glen Ventures provides capital, mentorship, strategic guidance, and access to an expert network, helping entrepreneurs scale their innovations in the healthtech space.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.